Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity

MLA

Li, Yiwei, et al. “Allosteric Inhibitors of Akt1 and Akt2: Discovery of [1,2,4]Triazolo[3,4-f][1,6]Naphthyridines with Potent and Balanced Activity.” Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 3, Feb. 2009, pp. 834–36. EBSCOhost, https://doi.org/10.1016/j.bmcl.2008.12.017.

APA

Li, Y., Liang, J., Siu, T., Hu, E., Rossi, M. A., Barnett, S. F., Defeo-Jones, D., Jones, R. E., Robinson, R. G., Leander, K., Huber, H. E., Mittal, S., Cosford, N., & Prasit, P. (2009). Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity. Bioorganic & Medicinal Chemistry Letters, 19(3), 834–836. https://doi.org/10.1016/j.bmcl.2008.12.017

Chicago

Li, Yiwei, Jun Liang, Tony Siu, Essa Hu, Michael A. Rossi, Stanley F. Barnett, Deborah Defeo-Jones, et al. 2009. “Allosteric Inhibitors of Akt1 and Akt2: Discovery of [1,2,4]Triazolo[3,4-f][1,6]Naphthyridines with Potent and Balanced Activity.” Bioorganic & Medicinal Chemistry Letters 19 (3): 834–36. doi:10.1016/j.bmcl.2008.12.017.